Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods and compositions using PDE4 inhibitors for the treatment and management of autoimmune and inflammatory diseases

Methods and compositions using PDE4 inhibitors for the treatment and management of autoimmune and inflammatory diseases

US Patent 9272035 · Granted Mar 1, 2016

Estimated economic value: $515,379,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treating systemic lupus erythematosus and the use of biomarkers as a2024
3-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperidine-2,6-dion2023
Treatment of immune-related and inflammatory diseases2022
Treatment of immune-related and inflammatory diseases2022
Combination therapies comprising apremilast and Tyk2 inhibitors2022
(+)-2-[1-(3-Ethoxy-4- methoxyphenyl)-2-methylsulfonylethyl]- 4-acetylaminoisoind2022
Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-ac2021
Methods for determining drug efficacy for the treatment of diffuse large B-cell 2021
3-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperidine-2,6-dion2021
Combination therapy for treatment of hematological cancers and solid tumors2021
Treatment of immune-related and inflammatory diseases2021
Treatment of immune-related and inflammatory diseases2021